"10.1371_journal.pone.0017387","plos one","2011-03-29T00:00:00Z","Andreas Binder; Denisa May; Ralf Baron; Christoph Maier; Thomas R Tölle; Rolf-Detlef Treede; Achim Berthele; Frank Faltraco; Herta Flor; Janne Gierthmühlen; Sierk Haenisch; Volker Huge; Walter Magerl; Christian Maihöfner; Helmut Richter; Roman Rolke; Andrea Scherens; Nurcan Üçeyler; Mike Ufer; Gunnar Wasner; Jihong Zhu; Ingolf Cascorbi","Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Department of Pain Management, BG Kliniken Bergmannsheil, Ruhr University Bochum, Bochum, Germany; Department of Neurology, Technische Universität München, Klinikum rechts der Isar, München, Germany; Center for Biomedicine and Medical Technology Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; Institute of Clinical and Cognitive Neuroscience, Central Institute for Mental Health, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; Department of Anaesthesiology, Ludwig-Maximilians-University München, München, Germany; Department of Neurology, University of Erlangen, Erlangen, Germany; Department of Neurology, University Medical Center, Johannes-Gutenberg-University of Mainz, Mainz and Department of Palliative Care, University of Bonn, Bonn, Germany; Department of Neurology, University of Würzburg, Würzburg, Germany","Conceived and designed the experiments: A. Binder RB C. Maier TT RDT A. Berthele SH WM MU IC. Performed the experiments: A. Binder DM C. Maier HF JG VH C. Maihöfner RR AS NÜ MU JZ. Analyzed the data: A. Binder DM RB C. Maier TT RDT A. Berthele FF JG SH WM C. Maihöfner HR GW JZ IC. Wrote the manuscript: A. Binder DM RB FF IC. Involved in revising the paper: C. Maier TT RDT A. Berthele HF JG SH VH WM C. Maihöfner HR RR AS NÜ MU GW JZ.","A. Binder received support for travel from the BMBF, honoraria for lectures from Grünenthal, Allergan and Pfizer, payment for development of educational presentations from Pfizer and travel/accommodation expenses from Pfizer, Allergan and Grünenthal and his institution received financial support from the BMBF. RB received support for travel from the BMBF, has consultancies with and received honoraria and travel/accommodation expenses from Pfizer, Genzyme, Grünenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB, Lilly, Astellas, received grants from Pfizer, Grünenthal, Genzyme, received payment for development of educational presentations from Pfizer, Medtronic and his institution received financial support from the BMBF. TT is board member at Pfizer, Lilly, Boehringer Grünenthal, and has consultancies with and received travel /accommodation expenses from Pfizer, Lilly, Boehringer, Grünenthal, Mundipharma, UCB/Schwarz. A. Berthele received honoraria and travel/accommodations expenses from Pfizer and his institution a grant from the BMBF. JG received support for travel from the BMBF and her institution received financial support from the BMBF. VH's institution received financial support from the BMBF. CMh received honoraria from Pfizer and travel/accommodation expenses from Allergan. RR is a board member at Astellas Pharma and received honoraria for lectures from Lilly and Pfizer. GW received honoraria and travel/accommodation expenses from Grünenthal, Medtronic, Pfizer, Mundipharma, his institution received financial support from the BMBF and Pfizer Pharma, and he received financial support for research from the National Health and Medical Research Council of Australia (NHMRC), the EFIC-Grünenthal-Grant (EGG), the Ministry of Science, Commerce and Transportation of Schleswig-Holstein, Germany and the Alexander von Humboldt-Stiftung. IC received honoraria and travel/accommodation expenses from MSD, Bayer-Schering and Sanofi Aventis for lectures. DM, RDT, FF, HF, SH, CM, AS, MU, NÜ, JZ, WM, HR have disclosed no competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","03","Andreas Binder","AB",22,FALSE,1,1,1,1,TRUE,TRUE,TRUE,16,"2;3;5;6;8;9;10;11;12;13;15;16;18;19;20;21",TRUE
